166 related articles for article (PubMed ID: 25428394)
1. Iodine-125 brachytherapy improved overall survival of patients with inoperable stage III/IV non-small cell lung cancer versus the conventional radiotherapy.
Li W; Guan J; Yang L; Zheng X; Yu Y; Jiang J
Med Oncol; 2015 Jan; 32(1):395. PubMed ID: 25428394
[TBL] [Abstract][Full Text] [Related]
2. Repeated iodine-125 seed implantations combined with external beam radiotherapy for the treatment of locally recurrent or metastatic stage III/IV non-small cell lung cancer: a retrospective study.
Li W; Dan G; Jiang J; Zheng Y; Zheng X; Deng D
Radiat Oncol; 2016 Sep; 11(1):119. PubMed ID: 27623620
[TBL] [Abstract][Full Text] [Related]
3. CT-guided interstitial brachytherapy of inoperable non-small cell lung cancer.
Wang ZM; Lu J; Liu T; Chen KM; Huang G; Liu FJ
Lung Cancer; 2011 Nov; 74(2):253-7. PubMed ID: 21513997
[TBL] [Abstract][Full Text] [Related]
4. Combination of Iodine-125 brachytherapy and chemotherapy for locally recurrent stage III non-small cell lung cancer after concurrent chemoradiotherapy.
Yu X; Li J; Zhong X; He J
BMC Cancer; 2015 Oct; 15():656. PubMed ID: 26445227
[TBL] [Abstract][Full Text] [Related]
5. Mature follow-up for high-risk stage I non-small-cell lung carcinoma treated with sublobar resection and intraoperative iodine-125 brachytherapy.
Colonias A; Betler J; Trombetta M; Bigdeli G; Gayou O; Keenan R; Werts ED; Parda DS
Int J Radiat Oncol Biol Phys; 2011 Jan; 79(1):105-9. PubMed ID: 20382483
[TBL] [Abstract][Full Text] [Related]
6. Computed Tomography-Guided Interstitial High-Dose-Rate Brachytherapy in Combination With Regional Positive Lymph Node Intensity-Modulated Radiation Therapy in Locally Advanced Peripheral Non-Small Cell Lung Cancer: A Phase 1 Clinical Trial.
Xiang L; Zhang JW; Lin S; Luo HQ; Wen QL; He LJ; Shang CL; Ren PR; Yang HR; Pang HW; Yang B; He HL; Chen Y; Wu JB
Int J Radiat Oncol Biol Phys; 2015 Aug; 92(5):1027-1034. PubMed ID: 26194678
[TBL] [Abstract][Full Text] [Related]
7. Endobronchial brachytherapy and optimization of local disease control in medically inoperable non-small cell lung carcinoma: a matched-pair analysis.
Mantz CA; Dosoretz DE; Rubenstein JH; Blitzer PH; Katin MJ; Garton GR; Nakfoor BM; Siegel AD; Tolep KA; Hannan SE; Dosani R; Feroz A; Maas C; Bhat S; Panjikaran G; Lalla S; Belani K; Ross RH
Brachytherapy; 2004; 3(4):183-90. PubMed ID: 15607149
[TBL] [Abstract][Full Text] [Related]
8. Hypofractionated palliative radiotherapy (17 Gy per two fractions) in advanced non-small-cell lung carcinoma is comparable to standard fractionation for symptom control and survival: a national phase III trial.
Sundstrøm S; Bremnes R; Aasebø U; Aamdal S; Hatlevoll R; Brunsvig P; Johannessen DC; Klepp O; Fayers PM; Kaasa S
J Clin Oncol; 2004 Mar; 22(5):801-10. PubMed ID: 14990635
[TBL] [Abstract][Full Text] [Related]
9. Hypofractionated Image-guided Radiation Therapy (3Gy/fraction) in Patients Affected by Inoperable Advanced-stage Non-small Cell Lung Cancer After Long-term Follow-up.
Agolli L; Valeriani M; Bracci S; Nicosia L; DE Sanctis V; Enrici RM; Osti MF
Anticancer Res; 2015 Oct; 35(10):5693-700. PubMed ID: 26408745
[TBL] [Abstract][Full Text] [Related]
10. Phase III study of cisplatin, etoposide, and concurrent chest radiation with or without consolidation docetaxel in patients with inoperable stage III non-small-cell lung cancer: the Hoosier Oncology Group and U.S. Oncology.
Hanna N; Neubauer M; Yiannoutsos C; McGarry R; Arseneau J; Ansari R; Reynolds C; Govindan R; Melnyk A; Fisher W; Richards D; Bruetman D; Anderson T; Chowhan N; Nattam S; Mantravadi P; Johnson C; Breen T; White A; Einhorn L; ;
J Clin Oncol; 2008 Dec; 26(35):5755-60. PubMed ID: 19001323
[TBL] [Abstract][Full Text] [Related]
11. Anatomic segmentectomy and brachytherapy mesh implantation for clinical stage I non-small cell lung cancer (NSCLC).
Landreneau JP; Schuchert MJ; Weyant R; Abbas G; Wizorek JJ; Awais O; Reamer MM; Luketich JD; Landreneau RJ
Surgery; 2014 Feb; 155(2):340-6. PubMed ID: 24314884
[TBL] [Abstract][Full Text] [Related]
12. Iodine125 interstitial brachytherapy in the treatment of carcinoma of the lung.
Fleischman EH; Kagan AR; Streeter OE; Tyrell J; Wollin M; Leagre CA; Harvey JC
J Surg Oncol; 1992 Jan; 49(1):25-8. PubMed ID: 1312654
[TBL] [Abstract][Full Text] [Related]
13. [Efficacy of permanent interstitial implantation of 125I seeds for solitary brain metastasis from non-small cell lung carcinoma].
Wang ZM; Wu J; Wang GC; Ren JL; Kjelle D
Ai Zheng; 2002 Oct; 21(10):1145-8. PubMed ID: 12508663
[TBL] [Abstract][Full Text] [Related]
14. The efficacy of iodine-125 permanent brachytherapy versus intensity-modulated radiation for inoperable salivary gland malignancies: study protocol of a randomised controlled trial.
Liu SM; Wang HB; Sun Y; Shi Y; Zhang J; Huang MW; Zheng L; Lv XM; Zheng BM; Reilly KH; Yan XY; Ji P; Wu YF; Zhang JG
BMC Cancer; 2016 Mar; 16():193. PubMed ID: 26951097
[TBL] [Abstract][Full Text] [Related]
15. Intraoperative brachytherapy using Gelfoam radioactive plaque implants for resected stage III non-small cell lung cancer with positive margin: a pilot study.
Nori D; Li X; Pugkhem T
J Surg Oncol; 1995 Dec; 60(4):257-61. PubMed ID: 8551736
[TBL] [Abstract][Full Text] [Related]
16. Permanent iodine-125 interstitial planar seed brachytherapy for close or positive margins for thoracic malignancies.
Mutyala S; Stewart A; Khan AJ; Cormack RA; O'Farrell D; Sugarbaker D; Devlin PM
Int J Radiat Oncol Biol Phys; 2010 Mar; 76(4):1114-20. PubMed ID: 19540065
[TBL] [Abstract][Full Text] [Related]
17. Robotic brachytherapy and sublobar resection for T1 non-small cell lung cancer in high-risk patients.
Blasberg JD; Belsley SJ; Schwartz GS; Evans A; Wernick I; Ashton RC; Bhora FY; Connery CP
Ann Thorac Surg; 2010 Feb; 89(2):360-7. PubMed ID: 20103299
[TBL] [Abstract][Full Text] [Related]
18. [Standards, Options and Recommendations for the management of stage I or II primary bronchial cancers treated exclusively with radiotherapy].
Touboul E; Lagrange JL; Theobald S; Astoul P; Baldeyrou P; Bardet E; Bazelly B; Bréchot J; Breton JL; Douillard JY; Grivaux M; Jacoulet P; Khalil A; Le Chevalier T; Lemarie E; Martinet Y; Massard G; Milleron B; Moro-Sibilot D; Paesmans M; Pujol JL; Quoix AE; Ranfaing E; Rivière A; Sancho-Garnier H; Souquet PJ; Spaeth D; Stoebner-Delbarre A; Thiberville L; Vaylet F; Vergnon JM; Westeel V; Depierre A
Cancer Radiother; 2001 Aug; 5(4):452-63. PubMed ID: 11521393
[TBL] [Abstract][Full Text] [Related]
19. Intraoperative 125I brachytherapy for high-risk stage I non-small cell lung carcinoma.
Chen A; Galloway M; Landreneau R; d'Amato T; Colonias A; Karlovits S; Quinn A; Santucci T; Kalnicki S; Brown D
Int J Radiat Oncol Biol Phys; 1999 Jul; 44(5):1057-63. PubMed ID: 10421539
[TBL] [Abstract][Full Text] [Related]
20. Intraoperative (125)I Vicryl mesh brachytherapy after sublobar resection for high-risk stage I non-small cell lung cancer.
Voynov G; Heron DE; Lin CJ; Burton S; Chen A; Quinn A; Santos R; Colonias A; Landreneau RJ
Brachytherapy; 2005; 4(4):278-85. PubMed ID: 16344258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
